Brain HealthDual Receptor Strategy Reverses Alzheimer's Memory Loss in Mouse Models
Alzheimer's disease disrupts the brain's balance between excitation and inhibition, partly by allowing amyloid-beta (Aβ) to block two key receptors — α7- and α4β2-nicotinic acetylcholine receptors (nAChRs) — on inhibitory brain cells. This silences protective interneurons and lets excitatory neurons run out of control. Researchers at Colorado State University showed that these two receptor subtypes each control a distinct class of hippocampal inhibitory cell: α7 governs parvalbumin-positive cells and α4β2 governs somatostatin-positive cells. Critically, stimulating either receptor alone was not enough — only co-activating both reversed hippocampal overexcitability, restored memory-related brain rhythms, rescued spatial memory, and lowered amyloid pathology in mouse models of Alzheimer's disease. The findings point to combination nAChR therapy as a more effective approach than single-target drugs for Alzheimer's.
